Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Medizone/OTC: MZEI (AIDS and Hepatitis B Treatment) -- Ignore unavailable to you. Want to Upgrade?

To: andris who wrote (697)	4/5/1999 12:49:00 AM
From: Power of 0	Read Replies (1) \| Respond to of 783

One of the things that's interesting about this company is that they have had great success treating a few individuals for hepatitus C and are having tremendous results. Their funding should be coming shortly and they have shown excellent results but unfortunately not in double blind studies. That will be the next step. This company could be huge if they can show through clinical, repeatable studies that they can help and possibly cure some individuals with various viruses such as hepatitus C, HIV, Mad Cow Disease, etc. Some of the people they have working with them have tremendous backgrounds in working with viruses and hopefully will be involved in the research and funding of the company. If they can continue to repeat what they have done on a larger, scientific scale, the sky's the limit for this company. The sooner they get this thing researched the faster the public will be able to recieve needed help in these areas. Hopefully, this will be put on a fast track for research.